Full-Time
Project Manager
Currier Plastics
51-200 employees
Custom injection and blow molding manufacturer
No salary listed
No H1B Sponsorship
Rancho Cordova, CA, USA
In Person
Bachelor's
 Business & Strategy (1) |
|---|
Get referred to Currier Plastics
See people who can refer or advise you
- A bachelor's degree in Engineering, Manufacturing, Project Management, or a related field, or equivalent experience.
- At least 5 years of project management experience in manufacturing, including at least 3 years in injection molding or plastics processing.
- Strong knowledge of injection molding processes, tooling, materials, and equipment.
- Ability to manage multiple complex projects simultaneously.
- Proficiency with project management software such as Microsoft Project, Excel, Wrike, and IQMS or equivalent.
- Ability to interpret drawings and specifications.
- PMP certification or a Lean Six Sigma background is a plus.
- Experience with IQMS Delmiaworks is a plus.
- Lead and manage projects from initiation through completion while ensuring alignment with customer requirements and company objectives.
- Serve as the primary point of contact for customers, suppliers, and internal teams regarding project scope, progress, and deliverables.
- Develop and maintain detailed project plans, timelines, and budgets; monitor progress and adjust resources as needed.
- Oversee tooling build, validation, and qualification activities.
- Coordinate with engineering, quality, operations, and supply chain teams to ensure smooth project execution and production readiness.
- Monitor and mitigate project risks, implementing corrective actions where necessary.
- Track key performance indicators for cost, quality, and delivery.
- Ensure compliance with safety, regulatory, and quality standards.
- Drive continuous improvement initiatives in project management processes.
- PMP certification or a Lean Six Sigma background.
- Experience with IQMS Delmiaworks.
Currier Plastics manufactures custom plastic parts using injection and blow molding for healthcare, life sciences, packaging, personal care, and electronics. It provides end-to-end service from in-house design (CAD/CAM), rapid prototyping, tooling, molding, to secondary operations like assembly and packaging, all within ISO Class 7/8 cleanrooms and ISO 13485-compliant processes for medical devices. The company differentiates itself through full customization, manufacturing agility, and a focus on medical device components, including work for Siemens Healthineers. Its goal is to deliver reliable, fully designed and manufactured plastic components for medical devices and healthcare packaging with fast turnaround and high quality, leveraging automation and cleanroom capabilities to grow in healthcare and life sciences.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Auburn, New York
Founded
1982
Get referred to Currier Plastics
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 7, 2026 Sage expands Currier into early-stage design and development.
- January 2025 Springboard and MOS added West Coast capacity and new pharmaceutical relationships.
- Healthcare outsourcing keeps shifting toward single-partner suppliers with engineering, tooling, and cleanroom assembly.
What critics are saying
- Three acquisitions since January 2025 strain integration, systems, and culture across five sites.
- Sheridan Capital bought Currier in September 2025, forcing aggressive growth and debt discipline.
- Any ISO 7 or 8 quality failure would destroy medical-device trust and trigger customer exits.
What makes Currier Plastics unique
- Currier combines injection molding, blow molding, and cleanroom CDMO services under Andrew McLean.
- August 2026 Sage adds concept-to-commercialization engineering, closing the loop for medtech customers.
- Five facilities and 400,000 square feet create rare scale in regulated plastics manufacturing.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Flexible Spending Account/FSA
401(k) Company Match
Profit Sharing
Disability Insurance
Life Insurance
Tuition Reimbursement
Company Social Events
Paid Vacation
Paid Sick Leave
Paid Holidays
Growth & Insights and Company News
6 month growth
↓ -2%1 year growth
↓ -2%2 year growth
↓ -2%Sheridan Capital's Currier Plastics acquires Sage Product Development. Added Expertise Makes Currier a More Strategic and Comprehensive Partner to its Life Sciences Clients CHICAGO, IL - August 7, 2026 - Sheridan Capital Partners ("Sheridan") today announced that its portfolio company, Currier Plastics ("Currier"), has completed the strategic acquisition of Sage Product Development ("Sage"), an engineering, design and development provider that helps its medical device customers take their products from concept to commercialization. Sage, based in Foxborough, Massachusetts, has an impressive track record working with its clients to design and develop a range of medical devices, including disposables, reusables, implants, electro-mechanicals, flexible endoscopes, complex catheter-based systems and a range of other minimally invasive devices. Sage engineers partner with customers on early concept and feasibility, product development, project management, and contract manufacturing. Sage has worked with more than 100 clients, playing an instrumental role in more than 220 issued patents and a long-list of commercialized devices. "Sage is an impressive company that has helped its partners bring many medical devices to market," said Andrew McLean, CEO of Currier Plastics. "Sage enables Currier customers to work with a single, trusted partner across their product journey - from concept all the way through commercial-scale manufacturing." "My fellow co-founders, Jonathan O'Keefe and Amos Cruz, and I are tremendously excited about what this transaction means for both companies," said Jeffrey Cerier, Co-Founder of Sage. "I want to thank the Sage employee base for making our team such a trusted partner to our customers. As part of Currier, we will have greater resources to bring our services to more medical device companies and can leverage the combined experience of our two organizations. At the same time, by integrating our area of expertise, Currier becomes an even greater strategic partner to its life sciences customers." "The addition of Sage will strengthen Currier's position as a full-service contract development and manufacturing organization for the life sciences sector, and we are excited about what this combination will mean for Currier and Sage customers and employees," said Michael Bernard, Partner, and Brian McGregor, Principal, of Sheridan Capital Partners. About Sheridan Capital Partners. Sheridan Capital Partners is a private equity firm focused exclusively on partnering with businesses across the healthcare landscape, including outsourced services, products and manufacturing, providers, and software and technology. Sheridan's engaged operational approach brings strategic resources and deep industry expertise with the purpose of accelerating growth, building enduring value, and generating strong results. For more information, visit www.sheridancp.com/. About Currier Plastics. Founded in 1982 and based in Auburn, New York, Currier Plastics is a contract development and manufacturing organization serving life sciences customers with custom, precision plastic components in Class 7 and Class 8 cleanrooms, as well as value-added services such as design engineering, material selection, and cleanroom assembly. For more information, visit www.currierplastics.com. About Sage. Sage Product Development, Inc. provides fast, efficient and creative product development services to medical device companies. The team is comprised of focused, experienced medical device engineers who know what it takes to develop successful products for startups, multinational companies, and everyone in between. Sage leverages its high level of experience to solve technical challenges and meet product development needs in a timely, efficient and highly personalized manner. For more information, visit www.sagepd.com. This press release includes statements provided by Andrew McLean, Chief Executive Officer of Currier Plastics, and Jeffrey Cerier, Co-Founder of Sage Product Development, which has been acquired by Currier Plastics, a portfolio company of funds advised by Sheridan Capital Partners. Neither Mr. McLean nor Mr. Cerier is a client or investor of Sheridan. The portfolio company relationship presents a potential conflict of interest, as Sheridan benefits from the success of its portfolio companies. No compensation was paid for these statements.
Currier Plastics finalizes acquisitions of medtech-focused contract manufacturers. California-based custom molders Springboard Manufacturing and MOS Plastics will be fully integrated into Currier's operations. Currier Plastics Currier Plastics announced today that it has completed the strategic acquisitions of medical contract manufacturing businesses Springboard Manufacturing and MOS Plastics. Both businesses will be fully integrated into Currier. Private equity delivers on promised growth. Currier Plastics was acquired by Chicago-based private equity firm Sheridan Capital Partners in September of last year. At that time, healthcare industry veteran Andrew McLean was named CEO of the company and tasked with executing on organic and strategic M&A growth for the custom molder serving medtech OEMs. Springboard, based in Rancho Cordova, California, serves blue chip life sciences companies with contract manufacturing services, including custom-molded precision components, tooling, and assembly. Springboard has more than 200 employees operating across two facilities totaling 140,000 square feet, including Class 8 cleanrooms. Also located in California, San Jose - based MOS provides custom-molded precision components, tooling, and sub-assemblies, primarily to pharmaceutical, medical technology, and diagnostics customers. MOS has more than 120 employees operating in a 55,000-square-foot facility, offering Class 8 and 7 cleanroom manufacturing and device assembly. More cleanroom capacity and a West Coast footprint. "We are very excited to integrate Springboard and MOS into the Currier business," said McLean. "Our customers will benefit from the addition of significant cleanroom capacity, adjacent services, a West Coast footprint, and strong expertise serving pharmaceutical, medical device, and diagnostic customers." Sheridan co-founder and Partner Sean Dempsey touted the economies of scale that the acquisitions bring to Currier. "Completing these acquisitions so early in our ownership period accelerates our value creation plan for Currier while also providing new opportunities for employees and customers of the combined business," he added. Founded in 1982 in Auburn, NY, Currier Plastics has established an enviable reputation for expertise in molding tight-tolerance custom components in Class 7 and 8 cleanrooms for customers in the medtech and other highly regulated end markets. It also offers design, engineering, material selection, and assembly services. Currier Plastics at MD&M West. Currier will exhibit at MD&M West in Anaheim, CA, next month in booth 2399. MD&M West is a comprehensive manufacturing-focused trade show and conference for the medical technology, plastics, packaging, and automation sectors. It runs from Feb. 3 to 5, 2026, at the Anaheim Convention Center. The dealmakers. John Weber, former CEO of Springboard, has joined the Currier Board of Directors as part of the transaction. In addition, previous Springboard owner, HC Private Investments, has become a material Currier shareholder. Other terms of the transactions were not disclosed. The acquisitions were led by Sheridan's Dempsey, Michael Bernard, Brian McGregor, and Dimitri Kallioras. McDermott Will & Schulte LLP served as legal counsel to Sheridan Capital Partners and Currier. Debt financing was provided by Fidelity. Winston & Strawn LLP served as legal counsel to Springboard and HC Private Investments. MBS Advisors served as financial advisor and Ramsey Law Group served as legal advisor to MOS Plastics. Experience cutting-edge product solutions and global networking at the Plastics Manufacturing Sector, previously Plastec West. Connect with top companies in 3D Printing, Injection Molding, Coatings, Furnishing, and more, as they showcase the latest biocompatible polymers and injection molding innovations. Editor-in-chief of PlasticsToday since 2015, Norbert Sparrow has been an editor working within business-to-business media since 1996. Prior to taking the helm of PlasticsToday, Sparrow oversaw the editorial content of several media outlets devoted to the medical device manufacturing sector, including European Medical Device Manufacturer, European Medical Device Technology, and medtechinsider, and was instrumental in launching spin-off publications and websites for the French, Chinese, and Japanese medtech markets. During that time, he moderated conference sessions at plastics industry events, such as the MD&M (formerly Plastec) shows in North America; participated in panel discussions; and reported on relevant trade shows and conferences around the world. Sparrow studied journalism at the Centre Universitaire d'Etudes du Journalisme in Strasbourg, France, where he earned a master's degree. While living in France, he wrote extensively about popular music and film in regional daily newspapers such as L'Alsace as well as Creem magazine in the United States. He was one of the last reporters to interview German filmmaker Rainer Werner Fassbinder before his untimely death, and the interview published in Cinéaste magazine is often referenced in academic articles on the director's work and career. Upon returning to the United States in the mid-1980s, Sparrow was hired as associate editor at LA Parent, an award-winning monthly city magazine for parents. A few years later, he launched The Noise, an alternative monthly publication distributed in area high schools. That long, strange transatlantic trip ultimately led Sparrow to Canon Communications, where he started his B2B career in 1996 as editor of European Medical Device Manufacturer.
Sheridan Capital's Currier Plastics completes strategic acquisitions of Springboard Manufacturing and MOS Plastics. Acquisitions will Expand Services, Deepen Life Sciences Capabilities and Establish West Coast Presence CHICAGO, IL - January 8, 2025 - Sheridan Capital Partners ("Sheridan") today announced that its portfolio company, Currier Plastics ("Currier"), has completed the strategic acquisitions of medical contract manufacturing businesses Springboard Manufacturing ("Springboard") and MOS Plastics ("MOS"). Both businesses will be fully integrated into Currier. Terms of the transactions were not disclosed. Springboard, based in Rancho Cordova, California, serves blue chip life sciences customers with contract manufacturing services, including custom-molded precision components, tooling and assembly. Springboard has more than 200 employees operating across two facilities totaling 140,000 square feet, including meaningful Class 8 cleanroom space. MOS is a San Jose, California-based contract manufacturer, providing custom-molded precision components, tooling and sub-assemblies, primarily to pharmaceutical, medical technology and diagnostic customers. MOS has over 120 employees operating in one facility with 55,000 square feet, featuring Class 8 and Class 7 cleanroom manufacturing and device assembly. "We are very excited to integrate Springboard and MOS into the Currier business," said Currier CEO, Andrew McLean. "Our customers will benefit from the addition of significant cleanroom capacity, adjacent services, a West Coast footprint, and strong expertise serving pharmaceutical, medical device and diagnostic customers." "The additions of Springboard and MOS will strengthen Currier's position as a valued partner to a wider array of life sciences customers while also resulting in significant economies of scale," said Sean Dempsey, Co-founder and Partner at Sheridan. "Completing these acquisitions so early in our ownership period accelerates our value creation plan for Currier while also providing new opportunities for employees and customers of the combined business." John Weber, former CEO of Springboard, has joined the Currier Board of Directors as part of the transaction. In addition, previous Springboard owner, HC Private Investments, has become a material Currier shareholder, demonstrating their conviction in the strength and prospects for the combined companies. "Both Springboard and MOS will be better positioned to realize their full potential as part of Currier, benefiting from a dedicated sales force that neither business previously had, as well as operational resources that have enabled Currier to earn its strong reputation for quality and service," added Weber. The transactions were led by Sean Dempsey, Michael Bernard, Brian McGregor, and Dimitri Kallioras at Sheridan Capital Partners. McDermott Will & Schulte LLP served as legal counsel to Sheridan Capital Partners and Currier. Debt financing was provided by Fidelity. Winston & Strawn LLP served as legal counsel to Springboard and HC Private Investments. MBS Advisors served as financial advisor and Ramsey Law Group served as legal advisor to MOS Plastics. About Sheridan Capital Partners. Sheridan Capital Partners is a private equity firm focused exclusively on partnering with businesses across the healthcare landscape, including outsourced services, products and manufacturing, providers, and software and technology. Sheridan's engaged operational approach brings strategic resources and deep industry expertise with the purpose of accelerating growth, building enduring value, and generating strong results. For more information, visit www.sheridancp.com/. About Currier Plastics. Founded in 1982 and based in Auburn, New York, Currier Plastics is a contract manufacturer primarily serving life sciences customers with custom, precision plastic components in Class 7 and Class 8 cleanrooms, as well as value-added services such as design engineering, material selection, and cleanroom assembly. For more information, visit www.currierplastics.com. About HC Private Investments. HC Private Investments is a private equity firm focused on making investments in consumer and industrial manufacturing businesses. With a focus on being the first institutional investor in a business, HCPI seeks to partner with business owners, executives, and management teams to identify opportunities to remove impediments to growth, enabling companies to maximize their full value potential. For more information, please visit www.hcprivateinvest.com.
Currier Plastics, a NYC-based manufacturer of custom, precision plastic components, received an investment from Sheridan Capital Partners
Currier Plastics girds for growth with private equity support. Sheridan Capital Partners has acquired the custom blow and injection molding company serving the medtech sector. Under new leadership, Currier said it will execute on organic growth initiatives and strategic M&A. Nadzeya Haroshka/iStock via Getty Images Custom blow and injection molding company Currier Plastics has been acquired by Sheridan Capital Partners it was announced today. The Chicago-based private equity firm focuses on lower middle market buyouts and growth equity in the healthcare space, and has named Andrew McLean as the new CEO of Currier Plastics. Cleanroom molding capabilities. Founded in 1982 and based in Auburn, NY, Currier has developed an excellent reputation for its technical capabilities and service to blue-chip customers in healthcare and other highly demanding and regulated end-markets, said Sheridan in the announcement. Currier molds tight-tolerance custom components in ISO Class 7 and Class 8 cleanrooms and also offers value-added services such as design engineering, material selection, and assembly. Currier founder and CEO john Currier said that Sheridan's expertise in consumer health and medical products makes it an ideal partner to build on the company's legacy. "The healthcare expertise Sheridan brings will be invaluable as we look to execute on organic growth initiatives and strategic M&A. In addition, this partnership and the leadership of our incoming CEO Andrew McLean will enable us to continue to invest in the talent and operational resources to continue providing world-class products and services to our growing customer base across multiple end markets," said Currier. Industry veteran takes the helm. McLean has more than 25 years of leadership experience in the medical device and pharmaceutical industries. Previous positions include CEO and president of medical device and pharmaceutical product design and contract manufacturer SteriPack Group, and CEO of Sirtex, a manufacturer of minimally invasive interventional oncology solutions. Earlier in his career, McLean held a number of senior sales, marketing, and business development roles at BD and Pfizer. "Currier's excellent reputation for quality, technical capabilities and customer service have been established over decades. I look forward to continuing and growing this legacy," said McLean. Mixed outlook for medtech M&A activity in 2025. Coming off a challenging 2024 for M&A activity in the medtech space, analysts expressed cautious optimism for 2025. Although activity decreased slightly in the first quarter of this year compared with Q4 2024, the upfront value of the deals increased dramatically from $2.7 billion to $9.2 billion, according to global law firm Morrison Foerster. Notably, Thermo Fisher Scientific recently announced that it will acquire Solventum's purification and filtration business for $4.1 billion, with the deal expected to close by year-end, reported Morrison Foerster. Earlier this year, Ingersoll Rand acquired Ireland-based Dave Barry Plastics, a specialized manufacturer of plastic products for the life science and healthcare industries. The acquisition represents a strategic expansion of Ingersoll Rand's capabilities in the critical cleanroom manufacturing sector. Nevertheless, headwinds abound that could put a strain on M&A activity. Morrison Foerster cites persistent concerns around inflation, geopolitical tensions, and policy shifts. The Trump administration's investigation into imposing Section 232 tariffs on a range of medical devices, which was made public last week, has also raised concerns in the medtech sector. Medical technology industry lobbyist AdvaMed issued a statement in response to the investigation stressing the world-leading home-grown medical innovation of a "robust and uniquely American industry" that will continue to thrive with a sound economic policy. "Lower tariffs will fuel more manufacturing and job growth in the US," argued AdvaMed. Editor-in-chief of PlasticsToday since 2015, Norbert Sparrow has been an editor working within business-to-business media since 1996. Prior to taking the helm of PlasticsToday, Sparrow oversaw the editorial content of several media outlets devoted to the medical device manufacturing sector, including European Medical Device Manufacturer, European Medical Device Technology, and medtechinsider, and was instrumental in launching spin-off publications and websites for the French, Chinese, and Japanese medtech markets. During that time, he moderated conference sessions at plastics industry events, such as the MD&M (formerly Plastec) shows in North America; participated in panel discussions; and reported on relevant trade shows and conferences around the world. Sparrow studied journalism at the Centre Universitaire d'Etudes du Journalisme in Strasbourg, France, where he earned a master's degree. While living in France, he wrote extensively about popular music and film in regional daily newspapers such as L'Alsace as well as Creem magazine in the United States. He was one of the last reporters to interview German filmmaker Rainer Werner Fassbinder before his untimely death, and the interview published in Cinéaste magazine is often referenced in academic articles on the director's work and career. Upon returning to the United States in the mid-1980s, Sparrow was hired as associate editor at LA Parent, an award-winning monthly city magazine for parents. A few years later, he launched The Noise, an alternative monthly publication distributed in area high schools. That long, strange transatlantic trip ultimately led Sparrow to Canon Communications, where he started his B2B career in 1996 as editor of European Medical Device Manufacturer.